Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -257,998 | -409,125 | -521,070 | -614,453 | -453,810 |
| Depreciation Amortization | 20,021 | 19,168 | 20,467 | 18,921 | 18,209 |
| Accounts receivable | 17,636 | -128,345 | -35,470 | -12,149 | -7,878 |
| Accounts payable and accrued liabilities | -11,736 | 29,179 | 3,843 | 48,406 | 46,361 |
| Other Working Capital | 80,284 | -115,955 | -107,998 | -13,141 | -56,459 |
| Other Operating Activity | 212,771 | 273,741 | 134,403 | 50,148 | -40,544 |
| Operating Cash Flow | $60,979 | $-331,336 | $-505,825 | $-522,269 | $-494,121 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,957 | 312,639 | 295,564 | 177,323 |
| PPE Investments | -9,600 | -516 | -2,588 | -5,220 | -28,671 |
| Purchase Of Investment | N/A | N/A | N/A | -225,304 | -279,478 |
| Investing Cash Flow | $-9,600 | $7,441 | $310,051 | $65,041 | $-130,826 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 145,172 | 147,470 | 530,257 | N/A |
| Debt Repayment | -24,843 | -12,298 | N/A | N/A | N/A |
| Common Stock Issued | 98,520 | 368,376 | 11,133 | 5,429 | 448,893 |
| Common Stock Repurchased | -19,682 | N/A | N/A | -110,949 | -25,561 |
| Other Financing Activity | -12,894 | -20,875 | -13,258 | -6,697 | -7,606 |
| Financing Cash Flow | $41,102 | $480,376 | $145,344 | $418,040 | $415,726 |
| Exchange Rate Effect | -28,559 | 24,641 | -6,503 | 37,607 | 45,657 |
| Beginning Cash Position | 633,067 | 424,361 | 481,371 | 470,187 | 691,542 |
| End Cash Position | 696,989 | 605,482 | 424,439 | 468,607 | 527,979 |
| Net Cash Flow | $63,922 | $181,121 | $-56,932 | $-1,580 | $-163,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,979 | -331,336 | -505,825 | -522,269 | -494,121 |
| Capital Expenditure | -9,600 | -1,544 | -2,643 | -15,266 | -28,671 |
| Free Cash Flow | 51,379 | -332,880 | -508,468 | -537,534 | -522,792 |